Plasma Multiomics Links Early‐Life Adversity to Disease and Cardiometabolic Health: A Population‐Based Cohort Study
Journal of the American Heart Association · 05.05.2026 · 15 (9)
DOI: 10.1161/jaha.125.047882 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of the American Heart Association, erschienen am 05.05.2026. Verfasst von Qida He und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Public Health City University of Hong Kong Hong Kong China. Hauptthemen laut MEDLINE: Metabolomics, Cardiovascular Diseases, Adverse Childhood Experiences. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Childhood adversity (CA) is associated with increased cardiovascular and cardiometabolic risk, but the molecular mechanisms remain unclear. We aimed to identify CA‐related metabolomic and proteomic signatures and evaluate their roles in linking CA to incident diseases.
Methods
This prospective cohort study included 153 225 participants aged 48 to 64 years. CA was assessed using the Childhood Trauma Screener‐5, capturing cumulative (0–5 domains) and individual adversity exposures. Plasma metabolomics and proteomics data were integrated to derive CA‐related molecular signatures. Cox proportional hazards model was used to evaluate associations between CA, molecular signatures, and 58 incident diseases and mortality. Mediation analyses quantified the role of multiomics signatures.
Results
Each additional CA domain was associated with higher risk of 49 of 58 incident diseases (hazard ratios [HRs], 1.024–1.338) and a 7.3% higher all‐cause mortality risk. Focusing on cardiometabolic health, the CA‐related metabolic and proteomic signatures were independently associated with incident disease. Per 1‐SD increase in the cumulative CA metabolic signature, the highest observed HR was 1.313 (95% CI, 1.278–1.349) for incident diabetes, and the risk for hypertension was also increased (HR, 1.136 95% CI, 1.114–1.159). Similarly, the proteomic signature was strongly associated with incident diabetes (HR, 1.645 95% CI, 1.489–1.818) and hypertension (HR, 1.223 95% CI, 1.155–1.295). The cumulative CA metabolic and proteomic signatures mediated up to 25.5% and 46.8% of the association with hypertension, respectively.
Conclusions
CA is associated with a broad spectrum of diseases and mortality, with particularly strong links to cardiometabolic health. Multiomics signatures partially mediated these associations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Public Health City University of Hong Kong Hong Kong China.
- State Key Laboratory of Cognitive Science and Mental Health Institute of Psychology, Chinese Academy of Sciences Beijing China.
- Department of Psychology University of Chinese Academy of Sciences Beijing China.
- Department of Biostatistics, School of Public Health Shandong Second Medical University Weifang China.
ORCID-Profile: Qida He, Mengtong Sun, Xianzhu Cong, Xun Sun, Yue Huang, Yujia Kong, Fuyan Shi, Suzhen Wang, Na Sun
Zitieren
APA
He, Q., Sun, M., Huang, F., Cong, X., Sun, X., Huang, Y., Wang, A., Kong, Y., Shi, F., Wang, S., & Sun, N. (2026). Plasma Multiomics Links Early‐Life Adversity to Disease and Cardiometabolic Health: A Population‐Based Cohort Study. Journal of the American Heart Association, 15(9). https://doi.org/10.1161/jaha.125.047882
Vancouver
He Q, Sun M, Huang F, Cong X, Sun X, Huang Y, et al. Plasma Multiomics Links Early‐Life Adversity to Disease and Cardiometabolic Health: A Population‐Based Cohort Study. Journal of the American Heart Association. 2026;15(9). doi:10.1161/jaha.125.047882
BibTeX
@article{He2026,
author = {He, Qida and Sun, Mengtong and Huang, Feng and Cong, Xianzhu and Sun, Xun and Huang, Yue and Wang, Aimin and Kong, Yujia and Shi, Fuyan and Wang, Suzhen and Sun, Na},
title = {Plasma Multiomics Links Early‐Life Adversity to Disease and Cardiometabolic Health: A Population‐Based Cohort Study},
journal = {Journal of the American Heart Association},
year = {2026},
volume = {15},
number = {9},
doi = {10.1161/jaha.125.047882}
}
EUVIMED